Image For Activity Cover
2022 SAT7 New Horizons in Treating Hypertrophic Cardiomyopathy: Practice Changing Molecules and Data
New Horizons in Treating Hypertrophic Cardiomyopathy: Practice Changing Molecules and Data

Cardiac myosin inhibitors: how do they work, and how could they improve your management of patients with hypertrophic cardiomyopathy (HCM)? Our experts discuss the latest data!


Authors: Theodore Abraham, MD, FACC, FASE; Sara Saberi, MD, MS; Anjali Owens, MD

All Credits Available
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™

Nurses - 1.25 ANCC Contact Hour(s) (1.25 contact hours are in the area of pharmacology)

Pharmacists - 1.25 Knowledge-based ACPE (0.125 CEUs)

CME / CE Released:
11/3/2022

Valid for credit through:
11/3/2023

Claim your credit at the Medscape site.
See More at New Horizons in Treating Hypertrophic Cardiomyopathy: Practice Changing Molecules and Data
Summary
Cost: See the price at https://www.medscape.org/viewarticle/982948
Credit:
Claim your credits at https://www.medscape.org/viewarticle/982948
Recommended
Powered by Oasis.